Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Parasomnias 2Lung Neoplasms 2Weight Loss 1Uveal Melanoma 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Smith-Magenis Syndrome 1Sleep Wake Disorders 1Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Breast Cancer - Female 1Barrett Esophagus 1Autism Spectrum Disorder 1Anorexia 1Angelman Syndrome 1

Interventions

Bevacizumab 5Leucovorin 4Irinotecan 4Fluorouracil 4Oxaliplatin 3Capecitabine 3Drug Therapy 2trifluridine tipiracil drug combination 1romiplostim 1napabucasin 1entecavir 1encorafenib 1durvalumab 1apatinib 1abelacimab 1Sunitinib 1Specimen Handling 1Sodium Chloride 1S-1 plus cisplatin 1Radiosurgery 1Palonosetron 1Oviposition 1Nutrition Assessment 1Nucleotides 1Methylphenidate 1Memantine 1Melatonin 1Magnetic Resonance Spectroscopy 1MAA868 1Levoleucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gastrointestinal Neoplasms × Melatonin × Clear all
NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
82 enrolled 7 charts
GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡